Bring AI, machine learning, data science and data together to support drug discovery and development—from target identification to biomarkers and development decisions.
Connect fit-for-purpose data, analytical methods and AI systems to the decisions that matter in drug development.
Organize, integrate and analyze complex data to support target assessment, biomarker development and drug-development decisions.
Develop and evaluate AI and ML approaches for drug discovery and development, grounded in the available data and intended use.
Apply LLMs and agentic systems to drug-development knowledge work, connecting information retrieval, analysis and human review.
CloudBioInfoAI, ML & data consultancy
CloudBioInfo focuses on AI, machine learning, data science and data—and their practical application to drug discovery and development.
From data integration and analytical modeling to foundation models, LLMs and agentic workflows, each engagement connects technical capability to a defined drug-development use case. Data quality, fit-for-purpose evaluation and human oversight guide the approach.
Start with a defined question. Build an engagement around the work needed to answer it.
Define the drug-development use case, available data, constraints and decisions the work needs to support.
Scope the data pipeline, analysis, AI model or agent workflow, with clear deliverables and evaluation criteria.
Translate findings into a documented handoff, practical recommendations and next steps.
Engagements can be scoped around advisory work, hands-on development or ongoing collaboration.
Share your AI, ML or data challenge, its drug-development application and the support you’re looking for.
